版本:
中国

更多 公司(英文) 新闻

Atea Pharma's COVID-19 treatment fails to meet study goal

Atea Pharmaceuticals said on Tuesday a mid-stage trial testing its experimental COVID-19 treatment failed to meet the main goal of reducing the amount of SARS-CoV-2 virus in patients with mild or moderate disease. (Reporting by Mrinalika Roy in Bengaluru; Editing by Shailesh Kuber)